Pfizer Inc. is recalling 98,410 vials of DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL) because of discolored solution caused by cracked vials. DOBUTamine (dobutamine) is a medication used in hospital settings for the short-term treatment of heart failure. The affected product was distributed by Hospira, Inc. and is intended for intravenous use only.
Cracked vials can allow contaminants to enter the solution, compromising its sterility and causing it to change color. Administering a non-sterile medication directly into a patient's bloodstream could result in serious infections or other life-threatening health complications.
Recall #: D-0489-2025; Distributed by Hospira, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.